Efficacy of mometasone furoate nasal spray in the treatment of acute rhinosinusitis

Abstract Background Acute rhinosinusitis (ARS) refers to a group of disorders characterized by inflammation of the respiratory epithelium of the nose and paranasal sinuses lasting from 7 to 28 days. In the treatment of ARS in addition to an antibiotic, intranasal corticosteroids hasten the clearance...

Full description

Bibliographic Details

Published in:	The Egyptian Journal of Otolaryngology
Main Authors:	Sandeep Shrestha, Rupesh Raj Joshi, Swikriti Shrestha
Format:	Article
Language:	English
Published:	SpringerOpen 2023-01-01
Subjects:	Acute rhinosinusitis (ARS) Mometasone furoate nasal spray (MFNS) Sino-Nasal Outcome Test-22 (SNOT-22)
Online Access:	https://doi.org/10.1186/s43163-023-00380-9